{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:31:26Z","timestamp":1792445486047,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["F31CA119954"],"award-info":[{"award-number":["F31CA119954"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["P30CA044579"],"award-info":[{"award-number":["P30CA044579"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01CA134060"],"award-info":[{"award-number":["R01CA134060"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01CA190665"],"award-info":[{"award-number":["R01CA190665"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["T32AI007496"],"award-info":[{"award-number":["T32AI007496"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["T32GM007267"],"award-info":[{"award-number":["T32GM007267"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.prp.2021.153527","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T05:32:26Z","timestamp":1623907946000},"page":"153527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Phospho-\u03b2-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues, and associations with expression of PD-L1 and PD-L2"],"prefix":"10.1016","volume":"224","author":[{"given":"Joel","family":"Pinczewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Craig L.","family":"Slingluff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153527_bib1","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1242\/jcs.064782","article-title":"Formation of extra centrosomal structures is dependent on beta-catenin","volume":"123","author":"Bahmanyar","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.prp.2021.153527_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/gad.1596308","article-title":"beta-Catenin is a Nek2 substrate involved in centrosome separation","volume":"22","author":"Bahmanyar","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2021.153527_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.280.5363.596","article-title":"Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta","volume":"280","author":"Behrens","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.prp.2021.153527_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Chien","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2021.153527_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ydbio.2011.06.029","article-title":"Phosphorylated \u03b2-catenin localizes to centrosomes of neuronal progenitors and is required for cell polarity and neurogenesis in developing midbrain","volume":"357","author":"Chilov","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.prp.2021.153527_bib6","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/sj.onc.1202627","article-title":"The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors","volume":"18","author":"Crawford","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153527_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/modpathol.3880546","article-title":"Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations","volume":"15","author":"Demunter","year":"2002","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc."},{"key":"10.1016\/j.prp.2021.153527_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191115","article-title":"\u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion","volume":"217","author":"Du","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2021.153527_bib9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2021.153527_bib10","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/sj.onc.1205711","article-title":"The Nek2 protein kinase: a novel regulator of centrosome structure","volume":"21","author":"Fry","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153527_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/nyas.14027","article-title":"The Wnt signaling pathway: a potential therapeutic target against cancer","volume":"1443","author":"Ghosh","year":"2019","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.prp.2021.153527_bib12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.283.5408.1739","article-title":"Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin","volume":"283","author":"Hamada","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.prp.2021.153527_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200684","article-title":"\u03b2-Catenin regulates tumor-derived PD-L1","volume":"217","author":"Han","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2021.153527_bib14","article-title":"Wnt inhibition sensitizes PD-L1 blockade therapy by overcoming bone marrow-derived myofibroblasts-mediated immune resistance in tumors","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2021.153527_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0960-9822(98)70229-5","article-title":"Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin","volume":"8","author":"Itoh","year":"1998","journal-title":"Curr. Biol.: CB"},{"key":"10.1016\/j.prp.2021.153527_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2133.2001.04336.x","article-title":"Loss of beta-catenin expression associated with disease progression in malignant melanoma","volume":"145","author":"Kageshita","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.prp.2021.153527_bib17","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1074\/jbc.C400035200","article-title":"Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle","volume":"279","author":"Kaplan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2021.153527_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.10893","article-title":"Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome","volume":"103","author":"Kielhorn","year":"2003","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"key":"10.1016\/j.prp.2021.153527_bib19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1054\/bjoc.2001.2160","article-title":"gp100\/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+ T cells","volume":"85","author":"Kierstead","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2021.153527_bib20","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/s41467-021-22407-6","article-title":"Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2021.153527_bib21","first-page":"3383","article-title":"Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma","volume":"9","author":"Maelandsmo","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2021.153527_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.200811108","article-title":"Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion","volume":"186","author":"Maher","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2021.153527_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cardiores.2003.08.005","article-title":"Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts","volume":"60","author":"Masuelli","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.prp.2021.153527_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1091\/mbc.e13-06-0349","article-title":"Nek2 phosphorylates and stabilizes \u03b2-catenin at mitotic centrosomes downstream of Plk1","volume":"25","author":"Mbom","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.prp.2021.153527_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/modpathol.3800562","article-title":"Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome","volume":"19","author":"Nakopoulou","year":"2006","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc."},{"key":"10.1016\/j.prp.2021.153527_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1235107","article-title":"PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome","volume":"5","author":"Obeid","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2021.153527_bib27","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1091\/mbc.e03-01-0865","article-title":"Beta-catenin regulation during the cell cycle: implications in G2\/M and apoptosis","volume":"14","author":"Olmeda","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.prp.2021.153527_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.116.4.989","article-title":"Molecular organization of the uvomorulin-catenin complex","volume":"116","author":"Ozawa","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.prp.2021.153527_bib29","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008052","article-title":"Wnt signaling in cancer","volume":"4","author":"Polakis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2021.153527_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00008390-200204000-00013","article-title":"Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines","volume":"12","author":"Pollock","year":"2002","journal-title":"Melanoma Res."},{"key":"10.1016\/j.prp.2021.153527_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0002-9440(10)65278-9","article-title":"Frequent nuclear\/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma","volume":"154","author":"Rimm","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2021.153527_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/mp.52.3.151","article-title":"Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours","volume":"52","author":"Sanders","year":"1999","journal-title":"Mol. Pathol.: MP"},{"key":"10.1016\/j.prp.2021.153527_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2021.153527_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.prp.2021.153527_bib35","series-title":"Protein-Protein Interactions as New Drug Targets. Handbook Exp Pharmacol","first-page":"261","article-title":"An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics","author":"Takemaru","year":"2008"},{"key":"10.1016\/j.prp.2021.153527_bib36","doi-asserted-by":"crossref","first-page":"14889","DOI":"10.1073\/pnas.0604045103","article-title":"Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy","volume":"103","author":"Zarling","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821001886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821001886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:48:04Z","timestamp":1759733284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"alternative-id":["S0344033821001886"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153527","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phospho-\u03b2-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues, and associations with expression of PD-L1 and PD-L2","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153527"}}